Aaron Muth
Overview
Explore the profile of Aaron Muth including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
1304
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Chavan T, Muth A
Future Med Chem
. 2021 Aug;
13(19):1679-1694.
PMID: 34410182
α-Mangostin is a xanthone natural product isolated as a secondary metabolite from the mangosteen tree. It has attracted a great deal of attention due to its wide-ranging effects on certain...
12.
Parvathaneni V, Elbatanony R, Goyal M, Chavan T, Vega N, Kolluru S, et al.
Int J Mol Sci
. 2021 May;
22(9).
PMID: 33946414
There is growing evidence that repurposed drugs demonstrate excellent efficacy against many cancers, while facilitating accelerated drug development process. In this study, bedaquiline (BDQ), an FDA approved anti-mycobacterial agent, was...
13.
Kanabar D, Kabir A, Chavan T, Kong J, Yoganathan S, Muth A
Bioorg Med Chem Lett
. 2021 Apr;
43:128043.
PMID: 33865970
No abstract available.
14.
Parvathaneni V, Kulkarni N, Muth A, Kunda N, Gupta V
Ther Deliv
. 2020 Nov;
12(2):105-110.
PMID: 33198605
No abstract available.
15.
Kanabar D, Muth A
Future Med Chem
. 2020 Sep;
12(18):1603-1606.
PMID: 32892644
No abstract available.
16.
Kanabar D, Farrales P, Kabir A, Juang D, Gnanmony M, Almasri J, et al.
Bioorg Med Chem Lett
. 2020 Aug;
30(17):127372.
PMID: 32738965
Gankyrin is an oncoprotein overexpressed in numerous cancer types and appears to play a key role in regulating cell proliferation, cell growth, and cell migration. These roles are largely due...
17.
Wang X, Parvathaneni V, Shukla S, Kulkarni N, Muth A, Kunda N, et al.
Int J Biol Macromol
. 2020 Jul;
164:638-650.
PMID: 32693132
Resveratrol (RES), a natural polyphenol in fruits, has shown promising anti-cancer properties. Due to its relative low toxicity which limits the adverse effects observed for conventional chemotherapeutics, RES has been...
18.
Wang X, Parvathaneni V, Shukla S, Kanabar D, Muth A, Gupta V
AAPS PharmSciTech
. 2020 Jul;
21(5):183.
PMID: 32632576
Pulmonary drug delivery is a noninvasive therapeutic approach that offers many advantages including localized drug delivery and higher patient compliance. As with all formulations, the low aqueous solubility of a...
19.
Parvathaneni V, Kulkarni N, Chauhan G, Shukla S, Elbatanony R, Patel B, et al.
Mater Sci Eng C Mater Biol Appl
. 2020 Jul;
115:111139.
PMID: 32600728
New drug and dosage form development faces significant challenges, especially in oncology, due to longer development cycle and associated scale-up complexities. Repurposing of existing drugs with potential anti-cancer activity into...
20.
Shukla S, Kulkarni N, Farrales P, Kanabar D, Parvathaneni V, Kunda N, et al.
Pharm Res
. 2020 Mar;
37(3):67.
PMID: 32166411
Purpose: This exploration is aimed at developing sorafenib (SF)-loaded cationically-modified polymeric nanoparticles (NPs) as inhalable carriers for improving the therapeutic efficacy of SF against non-small cell lung cancer (NSCLC). Methods:...